Ligand validation:3EVA

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 3EVA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EVA_SAH_A_901	55%	42%	0.127	0.895	0.82	1.42	1	2	0	0	100%	1
3EVD_SAH_A_903	78%	43%	0.091	0.932	0.83	1.38	-	2	0	0	100%	1
3EVB_SAH_A_901	76%	43%	0.1	0.937	0.78	1.42	-	2	0	0	100%	1
3EVF_SAH_A_901	71%	43%	0.105	0.925	0.81	1.39	1	3	0	0	100%	1
3EVE_SAH_A_901	64%	42%	0.104	0.903	0.8	1.42	-	2	1	0	100%	1
3EVC_SAH_A_901	64%	42%	0.097	0.893	0.81	1.41	-	2	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.